What is Triangle Biotechnology?
Triangle Biotechnology is at the forefront of simplifying complex and costly life science sample preparation processes. The company offers advanced solutions for critical research applications, including DNA shearing for next-generation sequencing, chromatin shearing for ChIP assays, and efficient cell lysis protocols. By providing fast, simple, and affordable sample prep systems, Triangle Biotechnology is dedicated to accelerating scientific discovery and empowering researchers to delve deeper into their work.
How much funding has Triangle Biotechnology raised?
Triangle Biotechnology has raised a total of $36K across 1 funding round:
Debt
$36K
Debt (2021): $36K with participation from PPP
Key Investors in Triangle Biotechnology
PPP
Public-Private Partnership
What's next for Triangle Biotechnology?
With significant Series B/C stage funding, Triangle Biotechnology is poised for accelerated growth and market penetration. The recent capital infusion is expected to fuel further development of their innovative sample preparation technologies and expand their collaborative efforts with researchers. This strategic investment will likely enable the company to scale its operations, enhance its product offerings, and solidify its position as a key player in the life science tools market, ultimately driving further advancements in biological research.
See full Triangle Biotechnology company page
